0.60 USD
▲-0.00+4.38%
盘后 0.56 -2.38%
2026-08-03
市值
$6.45M
市盈率
—
EPS
-2.77
股息率
—
52 周区间
0.55 – 1.51
成交量
257.44K
Beta
0.68
目标价
—
52W 低 0.5552W 高 1.51
价格走势
公司简介
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement...